Page 2 - South Korean (KOSPI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Apr 20, 2024

Explore the South Korean (KOSPI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

250 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A084990

Helixmith
₩4,475.001.5%-49.0%₩219.4bn/aPS52.2xn/an/a

A199800

ToolGen
₩61,100.000.7%32.5%₩484.4bn/aPS439xn/an/a

A317690

QuantaMatrix
₩3,665.004.7%-28.1%₩60.6bn/aPS19.4xn/an/a

A047920

HLB Pharmaceutical
₩31,650.000.6%122.3%₩444.4bn/an/an/an/a

A233250

Median Diagnostics
₩13,890.0011.2%-39.2%₩24.3bn/an/an/an/a

A170900

Dong-A ST
₩69,100.000.4%27.0%₩601.2b₩80,957.52PE54.1xE38.1%1.0%

A278650

HLB bioStepLtd
₩3,880.000.8%-12.7%₩332.4bn/aPS6.3xn/a0.6%

A046210

HLB PANAGENE
₩4,510.001.3%20.4%₩185.0bn/an/an/an/a

A191420

TegoScience
₩21,700.001.4%59.8%₩173.7bn/aPS22.4xn/an/a

A445680

Curiox Biosystems
₩49,000.000.6%n/a₩393.1bn/aPS57.9xn/an/a

A251280

Angiolab
₩5,110.0014.8%-34.4%₩15.3bn/an/an/an/a

A041960

Komipharm International
₩4,145.000.7%-40.3%₩290.8bn/aPS6.8xn/an/a

A000230

Ildong Holdings
₩8,610.002.0%-33.5%₩97.2bn/aPB2.5xn/a1.2%

A067080

DAE HWA Pharmaceutical
₩10,310.001.1%8.5%₩180.6bn/an/an/a1.5%

A032300

KOREA PHARMA
₩18,970.000.9%-9.0%₩206.9bn/aPE2470xn/an/a

A206650

EuBiologics
₩12,710.000.4%70.4%₩463.3b₩15,000.00PS6.7xE93.4%n/a

A038070

Seoulin BioscienceLtd
₩8,900.002.3%-25.5%₩76.2bn/aPB0.9xn/a1.1%

A352770

Clinomics
₩1,870.002.6%-69.0%₩61.3bn/aPS5.4xn/an/a

A066830

Genotech
₩1,828.0014.5%-29.7%₩10.2bn/an/an/an/a

A236340

MEDIZEN HUMANCARE
₩5,480.009.6%17.3%₩12.6bn/an/an/an/a

A347740

P&K Skin Research Center
₩2,835.001.3%-18.4%₩85.1bn/aPE17.7xn/a1.1%

A456190

Curachem
₩21,000.002.4%n/a₩36.8bn/an/an/an/a

A054670

Daehan New Pharm
₩7,920.000.6%-11.4%₩111.2bn/an/an/a1.3%

A204840

GL Pharm Tech
₩1,180.000.8%53.2%₩90.5bn/aPS3.5xn/an/a
Page 2 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.